Prohibits health benefit plans reviewing prescriptions for opioid addiction treatment.
Prohibits health benefit plans reviewing prescriptions for opioid addiction treatment.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure, or any generic or brand name prescription drug ordered by a primary care provider.
Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.
Authorizes office of health and human services (EOHHS) to establish coverage for obesity treatments, including medication. Office of health and human services would seek a 1115(a) waiver.
Prohibits a policy of individual health insurance coverage from requiring prior authorization for prescriptions of generic medication.
Prohibits health insurance providers from requiring preauthorization for in- network mental health or substance use disorder services.
This act would prohibit health insurance providers from requiring preauthorization for in- network mental health or substance use disorder services.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.